The average price reduction of "benefit the people and the people" exceeds 50%!

good news!

343 kinds of medicines are officially included in the national medical insurance and drug catalogs through formal review

On September 17, the State Medical Insurance Bureau officially announced the "List of Application Drugs for the Adjustment of National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogs in 2022, and a total of 343 drugs were officially reviewed.

Plus a big picture on the ups and downs to see the list of medicines

Some new coronary pneumonia therapy drugs passed the form of national medical insurance, work injury insurance and maternity insurance drug directory adjustment through formal review. A total of 343 drugs were reviewed in the form of the application of the drug list, including the first domestic new crown pneumonia oral medicine. At 198 types of categories such as Zoff Fixed Sets, Western Medicine and Chinese Pharmaceuticals and Ada Mipido Anti -Anti -Anti -Anti -Anti -Anti -Anti -Anti -Anti -Anti -Anti -Narcids Catalogs. Compared ——Phitigo ginseng vaginal expansion.

In the context of the normalization of the new crown epidemic prevention and control, from the first implementation of the independent application system of the medical insurance drug directory enterprise in 2020, the State Medical Insurance Administration attaches great importance to the treatment of new crown pneumonia. "Pharmaceuticals" as one of the application conditions, a number of new crown pneumonia treatment medication has been included in the medical insurance drug catalog. The National Medical Insurance Administration stated that during the application process, the new crown pneumonia therapy drugs that have been declared and reviewed through formal review will carry out follow -up work in accordance with procedures and strive to officially include the medical insurance directory at a reasonable price.

A number of rare diseases passed July through formal review. The National Medical Insurance Administration stated that this year did not set the time limit for the "approved listing after January 1, 2017" to apply for the medical insurance directory. As early as this year, when the medical insurance directory negotiation work was launched, the State Medical Insurance Bureau made it clear that the medical insurance directory would appropriately tilt to special groups such as patients with rare diseases and children. The list of drugs that passed the formal review contains a number of rare diseases, such as spinal muscle atrophy (SMA) therapeutic pharmaceutical Liste Polan oral solution, type Ⅰ Gobei disease treatment drug injection for hemididin, hemidin, Ease enzymes, type Ⅰ adhesive polysaccharides, special effects of adhesive and accumulation of Roninase, adurtlase enzyme enzyme α, etc.

Next, organize expert review and other tasks according to procedures

The National Medical Insurance Bureau stated that the adjustment of medical insurance and drug catalogs is divided into aspects of corporate application, form review, expert review, negotiating bidding, etc. The formal review is only one of them. Through form review, the drug is eligible to enter the next expert review session. Only by successfully adjusting the directory adjustment can it be eventually included in the national medical insurance directory.

In the next step, the National Medical Insurance Administration will organize the work of expert review in accordance with the requirements of the "Interim Measures for the Management of Basic Medical Insurance Drugs" and "2022 National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog". If the progress is smooth, the new version of the medical insurance drug catalog will be announced in November, and the implementation of the landing on January 1 next year will be announced.

Cumulative medical insurance and drug catalogs are included in 507 new drugs good medicine

Since the establishment of the State Medical Insurance Bureau in 2018, it has always attached great importance to the management of medical insurance and drug catalogs, and has carried out major reforms in the access method of medical insurance and drug directory. By establishing a dynamic adjustment mechanism for medical insurance and drug catalogs, the adjustment cycle has been sharply reduced from the longest 8 years in the past to 1 year, and 507 new medicines are included in 4 years. Adults increase to 2,860 kinds.

The shortcomings such as tumor drugs, chronic diseases, rare diseases, and children's medication are gradually supplemented. The drug structure and efficacy level in the medical insurance directory have been greatly optimized. Most of the drug guarantee in the treatment field is synchronized with the international synchronization, and the guarantee capacity has been significantly improved. Among them, 250 drugs were included in medical insurance through price negotiations. Many "sky -high drugs" talked about "civilian". Most drugs received the lowest price in the world, with an average price reduction of more than 50%.

Source: National Medical Insurance Bureau, Baotou Evening News

Editor: Zhang Xin

Editor: Wu Xiaoya Responsible: Editor Xing Tian: Yang Xiuqin

End

The third ecological environmental protection inspection team has a recovery of the telephone number and mailbox of the mailbox! Fully go to the new spring wisdom of Baiyun Epo's development! Baiyun Ebo continuously creates multiple first futures in the autonomous region! In 2022, how will Baiyun Ebo develop? You can understand here! [Epidemic prevention and control] Wear masks! wear mask! wear mask!

- END -